Neonatal thyroid-stimulating hormone concentrations in Belgium: a useful indicator for detecting mild iodine deficiency? by Vandevijvere, S et al.
Neonatal Thyroid-Stimulating Hormone Concentrations
in Belgium: A Useful Indicator for Detecting Mild Iodine
Deficiency?
Stefanie Vandevijvere1*, Wim Coucke1, Jean Vanderpas1, Caroline Trumpff1, Maarten Fauvart2,
Ann Meulemans2, Sandrine Marie3, Marie-Franc¸oise Vincent3, Roland Schoos4, Franc¸ois Boemer4,
Timothy Vanwynsberghe5, Eddy Philips6, Franc¸ois Eyskens6, Brigitte Wuyts7, Valbona Selimaj8, Bart Van
Overmeire8, Christine Kirkpatrick8, Herman Van Oyen1, Rodrigo Moreno-Reyes8
1 Scientific Institute of Public Health, Brussels, Belgium, 2Universite´ Libre de Bruxelles, Laboratoire de Pe´diatrie, Brussels, Belgium, 3Universite´ Catholique de Louvain,
Louvain-La-Neuve, Belgium, 4 Biochemical Genetics Laboratory, CHU Sart-Tilman, Lie`ge, Belgium, 5AZ Sint-Jan Brugge, Brugge, Belgium, 6 Provinciaal Centrum voor de
Opsporing van Metabole Aandoeningen, Antwerpen, Belgium, 7 Laboratory of Metabolic Disorders, UZ Gent, Gent, Belgium, 8Universite´ Libre de Bruxelles, Hoˆpital
Erasme, Bruxelles, Belgium
Abstract
It has been proposed that neonatal thyroid-stimulating hormone (TSH) concentrations are a good indicator of iodine
deficiency in the population. A frequency of neonatal TSH concentrations above 5 mU/L below 3% has been proposed as
the threshold indicating iodine sufficiency. The objective of the present study was to evaluate feasibility and usefulness of
nation-wide neonatal TSH concentration screening results to assess iodine status in Belgium. All newborns born in Belgium
during the period 2009–2011 (n = 377713) were included in the study, except those suffering from congenital
hypothyroidism and premature neonates. The frequency of neonatal TSH concentrations above 5 mU/L from 2009 to
2011 in Belgium fluctuated between 2.6 and 3.3% in the centres using the same TSH assay. There was a significant inverse
association between neonatal TSH level and birth weight. The longer the duration between birth and screening, the lower
the TSH level. Neonatal TSH levels were significantly lower in winter than in spring or autumn and significantly lower in
spring and summer than in autumn while significantly higher in spring compared to summer. In conclusion, despite that
pregnant women in Belgium are mildly iodine deficient, the frequency of neonatal TSH concentrations above 5 mU/L was
very low, suggesting that the neonatal TSH threshold proposed for detecting iodine deficiency needs to be re-evaluated.
Although neonatal TSH is useful to detect severe iodine deficiency, it should not be recommended presently for the
evaluation of iodine status in mildly iodine deficient regions.
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Introduction
Along with urinary iodine concentrations (UIC), it has been
proposed that neonatal thyroid-stimulating hormone (TSH)
concentrations are a good indicator for the prevalence of iodine
deficiency disorders (IDD) in the population [1–3]. Elevated
neonatal serum TSH concentration may indicate insufficient
supply of thyroid hormones to the developing foetal brain, and is
therefore the only measure that allows prediction of brain damage
due to iodine deficiency [2]. The neonatal thyroid has a low iodine
content compared to the adult thyroid, and hence neonatal iodine
turnover is much higher. In case of iodine deficiency, this turnover
is even higher, stimulating thereby TSH secretion. Consequently it
has been assumed that the neonatal thyroid is extremely sensitive
to iodine deficiency.
The World Health Organization (WHO) has proposed to use
the results of screening programs for congenital hypothyroidism in
neonates as an additional index for the evaluation of iodine status
of the population. A frequency of neonatal TSH concentrations
above 5 mU/L below 3% was proposed as indicating iodine
sufficiency. In mild iodine deficiency (MID) the frequency may be
3–19.9% and the frequencies of 20–39.9% and above 40% may be
found in moderate and severe iodine deficiency respectively [2;4].
Although TSH levels in neonates have already been used
previously for assessing the prevalence of iodine deficiency [5–8],
the cut-off of 5 mU/L, as set by the WHO, has been criticized [9–
11].
Some studies suggest that MID during pregnancy may impair
neurodevelopment in the offspring [12] and prevent them from
reaching their full intellectual potential. Correction of mild-to-
moderate iodine deficiency in primary school children was found
to improve cognitive and motor function [13].
Despite a worldwide successful implementation of iodine
supplementation programs over the last decades, iodine defi-
ciency remains a public health problem in Europe [14]. Since
2003, the number of European countries in which iodine
deficiency remains a public health problem decreased from 23 to
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14 [15], but it is a matter of concern that iodine deficiency has
re-emerged in countries thought to have sufficient iodine intake,
such as the UK [16]. Several surveys in the past indicated that
Belgium is affected by MID, and that this represents a substantial
economic burden to the Belgian health care system [17–19]. A
recent national survey on iodine status in Belgian school-aged
children showed a median UIC of 113.1 mg/L while 84.4 mg/L
among their mothers, indicating iodine sufficiency among
children and MID among their mothers [20]. The median
UIC in Belgian pregnant women (124.1 mg/L) also indicated
MID, as it was below 150 mg/L. Of all pregnant women
included, 59.3% had a UIC below 150 mg/L and 37.8% had a
UIC below 100 mg/L [21].
The objective of the present study was to evaluate feasibility and
usefulness of nation-wide neonatal TSH concentration screening
results to assess iodine status in Belgium. In order to compare TSH
concentrations among different laboratories, a ring test was
organized among the different centres in Belgium screening for
congenital hypothyroidism. In addition, factors influencing neo-
natal TSH concentrations in Belgium were investigated.
Methods
Ethics Statement
For the purpose of this study, already collected data were used.
Due to the huge sample size no informed consent was obtained
from the parents of the neonates in order to seek approval for the
use of the data for the purpose of this study. This study was
approved by the Privacy Commission in Belgium. The Privacy
Commission waived the need for written informed consent form in
order to use the data. The ring test was approved by the medical
ethical committee of the Erasme hospital and mothers of neonates
provided oral and written informed consent for participation of
their neonate in the ring test.
Data Collection
In Belgium there are 6 screening centers for congenital
hypothyroidism spread all over the country. Since 1976 all
neonates born in Belgium are screened for congenital hypothy-
roidism on day 3 to 5 after birth. Absorbing cards are distributed
to the obstetric clinics by the screening centres. Venous blood is
collected directly on the cards by the nurses via a heel stick. All
cards contain a unique identification code for each child. On
each card 4 circles are drawn with a diameter of 10 mm to
collect the blood spots. The blood is distributed equally over the
circles and the circles are filled completely. The remaining 3
circles are used for the screening of other metabolic diseases.
Following parameters are collected on the blood card for each
newborn: identification of the clinic, unique number of the child,
hospital of birth or general practitioner/midwife if born out of
hospital, sex of the child, birth date of the child, type of feeding
(breastfeeding), medications, duration of pregnancy and birth
weight.
Blood cards are dried at room temperature and transported
within 24 hours to the responsible screening centre for the analysis.
Analysis of Dried Blood Samples
For the quantitative determination of TSH on filter paper, a
time-resolved fluorimmoassay (Autodelfia or Delfia method) was
used by 4 out of 6 centres. This TSH assay is a solid phase, two-site
fluorimmunometric assay based on the direct sandwich technique
in which two monoclonal antibodies are directed against two
separate antigenic determinants on the TSH molecule [22]. The
analytical sensitivity of the assay is 2 mU/mL.
An in-house enzyme-linked immunosorbent assay (ELISA) was
used by 1 centre to quantify TSH in blood specimens dried on
filter paper. A 3 mm spot of calibrator or sample or internal
control was incubated during one night at 4uC to be fixed to a
capture monoclonal anti TSH antibody coated on the wells of
microplates. After washing, a solution of a second monoclonal
antibody chemically bound to horseradish peroxydase was added
and incubated for one hour at room temperature. After a new
washing step, a blue colour was developed for 10 minutes by
adding the substrate (H2O2) and the chromogen (TMB) solution.
After stopping with an acidic solution, the colour intensity was
measured by a spectrophotometer microplater reader at 450 nm.
The NIBSC 81/585 standard for TSH was used to prepare the
dried blood calibrators [23]. The analytical sensitivity of the
method is 3.9 mU/L.
A commercial ELISA method, the sandwich enzyme-immuno-
assay (EIA), the Quantase TM Neonatal Screening Assay provided
by Biorad, was used by 1 out of 6 screening centres. The sample
was incubated with a peroxidase-labelled anti-TSH monoclonal
antibody in a micro well coated with another anti-TSH
monoclonal antibody. After incubation, the wells were washed
free of unbound labeled antibody. TSH in the sample was
determined by the reaction of the bound conjugate with substrate
(TMB) producing a coloured product. The concentration of TSH
in the sample was proportional to the colour measured at 450 nm
in a plate reader. The analytical sensitivity of the method is
1.96 mU/mL.
In case of an increased TSH level (.15 mU/L or .20 mU/L,
depending on the analysis methodology used), an extra investiga-
tion is performed at the hospital, for eventual detection of
permanent primary hypothyroidism.
Ring Test
Lack of method standardization is a major drawback in
comparing data from different centres. A ring test is useful to be
able to facilitate intercentre comparisons and to calibrate
laboratories to each other to compare TSH level between
centres and/or analysis methodologies. This ring study was
approved by the medical ethical committee of the Erasme
hospital in Brussels. In this study blood from 100 neonates was
collected at the maternity of the Erasme hospital in Brussels
using a heparanized microtube. A blood spot of 50 ml was placed
on the special filter paper (S&S 903). After drying, these filter
papers were sent to the six screening centres in order to
determine TSH concentrations.
Statistical Analysis
A method and laboratory comparison using the results from the
samples was performed using the Deming regression model [24].
Whereas the ordinary linear regression method assumes that only
the Y measurements are associated with random measurement
errors, the Deming method takes measurement errors for both Y
and X measurements into account. For centre 5, using the ELISA
in-house method and centre 6, using the commercial ELISA
method, regression equations were determined to be able to
convert the TSH values from their method to the (Auto)delfia
method used by centre 1, 2, 3 and 4. The standard errors and
confidence intervals of the intercept and slope were estimated
using bootstrapping.
Because of the high variability between different analysis
methods, it was decided to use 6 different scenarios in order to
present neonatal TSH concentrations for Belgium over the
different years. In scenario 1 the regression equations used the
point estimators for both slope and intercept. In scenario 2 the
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lower limit of the confidence interval (CI) was used for both
intercept and slope while in scenario 3 the higher limits of
intercept and slope were used. In scenario 4 the lower limit of CI
for intercept and the higher limit of CI for slope were used and
in scenario 5 the other way around. In scenario 6 only the
neonatal TSH values from the first four centres using the same
analysis method were used to compare TSH over the different
years.
Since 2009 TSH levels of all neonates in Belgium are
electronically available by all 6 centres and collected in a central
database on a yearly basis. Neonates were excluded from this study
if they were affected by primary neonatal hypothyroidism and if
they were premature. In the first case all neonates with a TSH
level higher than 15 mU/L were excluded. Prematurity was
defined as a birth weight lower than 2500 g and/or pregnancy
duration lower than 37 weeks.
TSH values were log transformed after adding 1. Differences in
neonatal TSH levels in Belgium among the different years (2009,
2010, and 2011) were explored using analysis of variance
(ANOVA). Multiple pair wise comparisons were made with the
Tukey test.
Finally, to evaluate the effect of the factors birth weight,
pregnancy duration, duration between birth and screening date,
duration between birth and analysis date, year, sex and season on
neonatal TSH level, linear mixed models were used with screening
centre included as random effect.
Results
Ring Test
Results from the Deming regression comparing the different
centres can be found in Figure 1. There is a very good agreement
between the 4 centres using the (Auto)delfia method. There are
only significant differences between centres 1,2,3,4 and both
centre 5 and 6. Variability is high comparing centre 5 and 6 to
the other 4 centres (Figure 2). The regression equations to
convert TSH values of centre 5 and 6 to the Autodelfia method
are shown in Table 1. The 95% confidence interval for the
intercept shows that the intercept is not significantly different
from 0 in both cases, which means that both the analysis method
of centre 5 and centre 6 do not significantly differ with a constant
amount from the Autodelfia method. The 95% confidence
interval for the slope shows that in both cases the slope is
significantly different from 1 and there is a proportional
difference between the both the method of centre 5 and 6 and
the Autodelfia method.
TSH Concentrations in Neonates in Belgium
In Table 2 median and mean TSH values over the three
different years and using the 6 different scenarios are shown. For
all scenarios all pair wise comparisons between the different years
were significantly different.
For all scenarios TSH levels were highest in 2010 and decreased
again in 2011. Taking into account only the four centres using the
same method, TSH level slightly increased from 2009 to 2011.
According to the WHO criteria, the iodine status of Belgian
neonates is optimal or borderline sufficient as the percentage of
neonates with a TSH level higher than 5 mU/L is either lower
than 3% or around 3% for the different scenarios, except in 2010
for the scenarios using the upper limit of CI for the slope and/or
intercept.
Factors Affecting Neonatal TSH Concentrations in
Newborns
Extra information on birth weight, pregnancy duration, sex of
the neonate, season and duration between birth and screening,
was only available for 3 out of 6 centres (n = 78004). There was a
significant inverse association between neonatal TSH level and
birth weight while there was a significant positive association
between neonatal TSH level and pregnancy duration. The longer
the duration between birth and screening or birth and analysis, the
lower the TSH level (data not shown). In order to explore the
differences in TSH concentration over the different years and
seasons a mixed model was used. Differences of least square means
between years and seasons can be found in Table 3. Differences in
neonatal TSH concentrations between 2010 and 2011 were not
significantly different but neonatal TSH levels were significantly
lower in 2009 than in 2010 and 2011. Neonatal TSH levels were
significantly lower in winter than in spring or autumn and lower in
spring and summer than in autumn while significantly higher in
spring compared to summer. Results were the same in all 5
scenarios. In the scenario only taking into account the 4 centres
with the same method, TSH was significantly lower in 2010 and
2009 compared to 2011 but additional factors could not be taken
into account in this model.
Discussion
The frequency of neonatal TSH concentrations above 5 mU/L
in Belgium was unexpectedly low considering that pregnant
women in Belgium are mildly iodine deficient. This percentage
fluctuated between 2.6 and 3.3% from 2009 to 2011 in the centres
using the same TSH assay.
The WHO proposed that when a sensitive assay is used on
samples collected 3–4 days after birth a frequency of TSH
concentrations.5 mU/L less than 3% indicates iodine sufficiency
in the population [4]. However, although several studies attempted
to apply neonatal TSH values in determining population iodine
Figure 1. Results of Deming regression among the 6 neonatal
screening centres for congenital hypothyroidism in Belgium.
(Full line =Deming regression line; dotted line = 45u line). Centre 1:
Brussels; Centre 2: Gent; Centre 3: Brugge; Centre 4 : Antwerpen; Centre
5 : Lie`ge; Centre 6 : Louvain en Woluwe´.
doi:10.1371/journal.pone.0047770.g001
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status and some have proven to be successful [5;6;8;25], some have
provided conflicting or uncertain data [10;11].
The utilisation of neonatal TSH is an attractive method because
it is assumed that the thyroid of the newborn is very sensitive to
iodine status and even MID during pregnancy will cause an
increase in neonatal TSH secretion. In addition in countries where
such screening programme exists, the utilisation of neonatal TSH
concentrations does not imply an extra cost. Unfortunately in most
of the regions where iodine deficiency is severe such screening
programs are usually lacking. In Belgium however the situation is
complicated because there are 6 screening centres using 3 different
assay methods. Despite this heterogeneity and after applying
correction factors, all the centres showed concordant values
indicating a low frequency of TSH .5 mU/L.
In case of severe iodine deficiency neonatal TSH concentrations
are consistently high [3] and most of the conflicting results on
neonatal TSH for the evaluation of iodine status concern mildly
iodine deficient regions. A TSH frequency .5 mU/L below 3%
has been reported in several mildly iodine deficient regions
suggesting that neonatal TSH may not be sensitive enough to
evaluate iodine status when iodine deficiency is mild. A study from
Australia using a sensitive TSH assay found that only 2.2% of
neonates had a TSH value .5% despite a median UIC of 85 mg/l
among pregnant women [26]. In Belgium iodine status is
characterized by iodine sufficiency in school-aged children and
MID in pregnant women and in women of child-bearing age
[20;21]. Despite that pregnant women are mildly iodine deficient
the frequency of TSH values .5 mU/L in Belgium was low,
considering the results from the centres using the same TSH assay,
corroborating previous studies from mildly iodine deficient regions
[26]. Interestingly, a clinical trial performed in Belgium on iodine
supplementation in pregnant women did show differences in
neonatal thyroglobulin concentrations but not in TSH levels of
neonates born from women who received iodine supplements
compared to those who did not [27]. The change in median UIC
after iodine supplementation derived from the data published was
probably lower than 100 mg/L. This variation of iodine intake
reflected by an increase of the median UIC lower than 100 mg/L
may be too small to induce an increase in neonatal TSH but may
be capable of triggering an increase of neonatal thyroglobulin
concentrations.
In Switzerland the frequency of neonatal TSH .5 mU/L
decreased significantly from 2.9% to 1.7% with the increase in salt
iodine concentrations [28]. However this modification of TSH
frequency was associated with an increase in the median UIC in
pregnant women greater than 100 mg/L; from 138 mg/l to
249 mg/L. Altogether these results suggest that a low frequency
of TSH .5 mU/L cannot exclude MID during pregnancy or
cannot alone detect a small variation of iodine intake in the
population. It is possible that instead of applying a single cut-off of
blood TSH level, the trend of TSH concentrations may provide an
early indication of impending iodine deficiency as suggested in a
study from Ireland [9].
Table 1. Regression equations and 95% CI to convert TSH levels of centre 5 and 6 to Autodelphia method.
centre intercept intercept, CI(low) intercept, CI(high) slope slope, CI(low) slope, CI(high)
5 0,44 20.365 0.978 0.135 0.013 0.319
6 20.201 20.629 0.334 0.496 0.257 0.68
Centre 5: Lie`ge; Centre 6: Louvain en Woluwe´. CI confidence interval.
doi:10.1371/journal.pone.0047770.t001
Figure 2. Bland Altman plot of comparison of Method 1 (Autodelphia) used by centre 1,2,3,4 versus Method 2 (ELISA commercial
Biorad) used by centre 5. Mean difference: 23.854 mU/L (CI 24.291 to 23.417 mU/L) (left) and method 1 (Autodelphia) used by centre 1,2,3,4
versus method 3 (ELISA) used by centre 6; mean difference: 21.470 mU/L (CI 21.692 to 21.249 mU/L) (right).
doi:10.1371/journal.pone.0047770.g002
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Several factors, other than iodine intake influence neonatal
TSH concentration and may explain to some extent the conflicting
results when applied for the monitoring of iodine status. One of
the most relevant factors is related to the considerable variations of
TSH values obtained with the different available TSH assays as
shown in the present study. However in earlier publications
determining the appropriate neonatal TSH cut-off to detect iodine
deficiency this issue was not addressed [3] and it is possible that
some of the conflicting results may arise from a cut-off derived
from studies using different TSH assays. In addition neonatal TSH
is also affected by the mode of delivery [29], smoking behaviour of
the mother [30;31], use of iodine-containing antiseptics during
delivery [32] and multiple pregnancies [33].
In the present study, an inverse association was found between
neonatal TSH levels and birth weight and an inverse association
was found with duration between birth and screening, as shown
previously [34]. In a single centre in Northern England males
seemed to have higher TSH levels than females [35]. In Belgium
there was no difference in TSH levels between boys and girls. In
addition the frequency of neonatal transient hyperthyrotropinemia
appears significantly less in autumn than in spring, [36] such as
found also in the present study.
Although the use of neonatal TSH concentrations is attractive
for monitoring iodine status, many issues need to be addressed
before it can be recommended for this purpose, particularly in
mildly iodine deficient countries. The sensitivity of neonatal TSH
concentration in conditions of MID needs to be reassessed in view
of the conflicting data, suggesting that neonatal TSH may not be
as sensitive as previously thought. The hypersensitivity of the
neonatal thyroid to small variations of iodine intake also needs to
be re-evaluated and compared to neonatal thyroglobulin concen-
trations that may be more sensitive to smaller variations of iodine
intake during pregnancy. Finally the use of standard protocols for
sample blood collection and TSH assays is mandatory to be able to
compare results from different regions and to define appropriate
cut-offs.
In conclusion, despite that pregnant women in Belgium are
mildly iodine deficient, the frequency of neonatal TSH values
above 5 mU/L was unexpectedly low suggesting that the TSH
threshold proposed for detecting iodine deficiency needs to be re-
evaluated. Although neonatal TSH is useful to detect severe iodine
deficiency it should not be recommended presently for the































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3. Least square means of difference in TSH among
years and seasons, linear mixed model regression.
Effect Estimate* p
Year 2009–2010 20.035 ,0.001
Year 2009–2011 20.044 ,0.001
Year 2010–2011 20.009 0.057
season winter-spring 20.015 ,0.001
season winter-summer 20.006 0.110
season winter-autumn 20.026 ,0.001
season spring-summer 0.009 0.010
season spring-autumn 20.011 0.004
season summer-autumn 20.020 ,0.001
*transformed values.
doi:10.1371/journal.pone.0047770.t003
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